Search

Author/Creator Grivas, Petros

63. TROPHY-U-01: A Phase II Open-Label Study of Sacituzumab Govitecan in Patients With Metastatic Urothelial Carcinoma Progressing After Platinum-Based Chemotherapy and Checkpoint Inhibitors. Issue 22 (1st August 2021)

Authors:
Tagawa, Scott T.; Balar, Arjun V.; Petrylak, Daniel P.; Kalebasty, Arash Rezazadeh; Loriot, Yohann; Fléchon, Aude; Jain, Rohit K.; Agarwal, Neeraj; Bupathi, Manojkumar; Barthelemy, Philippe; Beuzeboc, Philippe; Palmbos, Phillip; Kyriakopoulos, Christos E.; Pouessel, Damien; Sternberg, Cora N.; Ho...
Journal:
Journal of clinical oncology
Issue:
Volume 39:Issue 22(2021)
Page Start:
2474
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

65. Utilization of Systemic Therapy in Patients With Cancer Near the End of Life in the Pre- Versus Postimmune Checkpoint Inhibitor Eras. Issue 11 (November 2021)

Authors:
Khaki, Ali Raza; Chennupati, Shasank; Fedorenko, Catherine; Li, Li; Sun, Qin; Grivas, Petros; Ramsey, Scott D.; Schwartz, Stephen M.; Shankaran, Veena
Journal:
JCO oncology practice
Issue:
Volume 17:Issue 11(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗